Conference
Combination therapy with IL-15 superagonist (ALT-803) and PD-1 blockade enhances human NK cell immunotherapy against ovarian cancer
Authors
Geller MA; Bendzick LA; Ryan C; Chu S; Lenvik A; Skubitz APN; Boylan KLM; Vogel RI; Miller J; Felices M
Volume
145
Publisher
Elsevier
Publication Date
June 1, 2017
DOI
10.1016/j.ygyno.2017.03.060
Conference proceedings
Gynecologic Oncology
ISSN
0090-8258